Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations

Frontotemporal lobar degeneration is heterogeneous; cases with tau- and synuclein-negative, ubiquitin-positive neuronal inclusions are the most common, and some have mutations in the gene for progranulin (PGRN). The purpose of this study was to determine whether there were distinctive clinical and neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with PGRN mutations. A retrospective review of medical records and semiquantitative neuropathologic analysis was performed on 18 PGRN(+) and 24 PGRN(−) cases. Clinically, PGRN(+) cases had more frequent language impairment and parkinsonism. Pathologically, PGRN(+) cases had smaller brains, more marked global atrophy, and more frontal atrophy. There was no difference in the frequency of hippocampal sclerosis. The pathology of PGRN(+) cases was relatively homogeneous, whereas PGRN(−) cases were more heterogenous. PGRN(+) cases had greater density of cortical ubiquitin-immunoreactive lesions, especially dystrophic neurites in layer II. Intranuclear inclusions were present in all PGRN(+) and 42% of PGRN(−) cases. The results suggest that frontotemporal lobar degeneration with ubiquitin-positive inclusions due to PGRN mutations has several characteristic features, including ubiquitin-immunoreactive neuritic pathology in superficial cortical layers and neuronal intranuclear inclusions. On the other hand, there is no histopathologic feature or combination of features that is pathognomonic. Neuronal intranuclear inclusions are virtually always present, but they can be detected in PGRN(−) cases.

[1]  A Danek,et al.  Frontotemporale Lobärdegenerationen , 2009 .

[2]  D. Dickson,et al.  Hippocampal sclerosis in tau-negative frontotemporal lobar degeneration , 2007, Neurobiology of Aging.

[3]  Nancy Johnson,et al.  Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. , 2007, Archives of neurology.

[4]  C. Jack,et al.  Frontotemporal lobar degeneration without lobar atrophy. , 2006, Archives of neurology.

[5]  S. Melquist,et al.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. , 2006, Human molecular genetics.

[6]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[7]  J. Trojanowski,et al.  Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. , 2006, The American journal of pathology.

[8]  Julie S. Snowden,et al.  Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype , 2006, Acta Neuropathologica.

[9]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[10]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[11]  Charles D. Smith,et al.  Novel Ubiquitin Neuropathology in Frontotemporal Dementia With Valosin-Containing Protein Gene Mutations , 2006, Journal of neuropathology and experimental neurology.

[12]  Ronald C Petersen,et al.  Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. , 2006, Archives of neurology.

[13]  F. Baas,et al.  Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. , 2006, Brain : a journal of neurology.

[14]  S. Melquist,et al.  A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. , 2006, Brain : a journal of neurology.

[15]  H. Horvitz,et al.  A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.

[16]  S Minoshima,et al.  Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.

[17]  D. Dickson,et al.  Ubiquitin Immunohistochemistry of Frontotemporal Lobar Degeneration Differentiates Cases With and Without Motor Neuron Disease , 2005, Alzheimer disease and associated disorders.

[18]  I. Mackenzie,et al.  Ubiquitin Immunohistochemistry Suggests Classic Motor Neuron Disease, Motor Neuron Disease With Dementia, and Frontotemporal Dementia of the Motor Neuron Disease Type Represent a Clinicopathologic Spectrum , 2005, Journal of neuropathology and experimental neurology.

[19]  J. Morris,et al.  Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.

[20]  D. Dickson,et al.  Screening for neurofilament inclusion disease using α-internexin immunohistochemistry , 2005, Neurology.

[21]  J. Trojanowski,et al.  Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias. , 2005, Journal of neuropathology and experimental neurology.

[22]  D. Dickson,et al.  Hippocampal sclerosis dementia , 2004, Neurology.

[23]  M N Rossor,et al.  Frontotemporal lobar degeneration and ubiquitin immunohistochemistry , 2004, Neuropathology and applied neurobiology.

[24]  M. Mesulam,et al.  Neuronal Ubiquitinated Intranuclear Inclusions in Familial and Non‐Familial Frontotemporal Dementia of the Motor Neuron Disease Type Associated with Amyotrophic Lateral Sclerosis , 2004, Journal of neuropathology and experimental neurology.

[25]  E. Cochran,et al.  Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders , 2004 .

[26]  F. Block,et al.  [Primary progressive aphasia]. , 2004, Der Nervenarzt.

[27]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[28]  Nick C Fox,et al.  Neurofilament inclusion body disease: a new proteinopathy? , 2003, Brain : a journal of neurology.

[29]  D. Dickson,et al.  Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy Brain Bank , 2003, Movement disorders : official journal of the Movement Disorder Society.

[30]  H. Feldman,et al.  Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases , 2003, Acta Neuropathologica.

[31]  D. Maraganore,et al.  Clinical correlates of the pathology underlying parkinsonism: A population perspective , 2002, Movement disorders : official journal of the Movement Disorder Society.

[32]  R. Petersen,et al.  Corticobasal Degeneration and Frontotemporal Dementia Presentations in a Kindred with Nonspecific Histopathology , 2002, Dementia and Geriatric Cognitive Disorders.

[33]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[34]  Andrew Kertesz,et al.  Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions , 2001, Acta Neuropathologica.

[35]  D. Mann,et al.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. , 2001, The American journal of pathology.

[36]  M. Farrer,et al.  Distinctive neuropathology revealed by α-synuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p , 2000, Acta Neuropathologica.

[37]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[38]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[39]  James Lowe,et al.  Establishing a Pathological Diagnosis in Degenerative Dementias , 1998, Brain pathology.

[40]  D. Pollen,et al.  Familial and sporadic Alzheimer's disease , 1996, Neurology.

[41]  Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[42]  Y. Hochberg.  A sharper Bonferroni procedure for multiple tests of significance , 1988 .